- Home
- Publications
- Publication Search
- Publication Details
Title
Psoriatic arthritis
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-12
DOI
10.1038/s41572-021-00293-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study
- (2021) Ennio Lubrano et al. JOURNAL OF RHEUMATOLOGY
- Comorbidities in psoriatic arthritis: a systematic review and meta-analysis
- (2021) Sonal Gupta et al. RHEUMATOLOGY INTERNATIONAL
- Tissue‐resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis
- (2021) Emmerik F. Leijten et al. Arthritis & Rheumatology
- Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
- (2021) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- The epidemiology of psoriatic arthritis: A literature review
- (2021) Paras Karmacharya et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Infection‑provoked psoriasis: Induced or aggravated (Review)
- (2021) Yan Teng et al. Experimental and Therapeutic Medicine
- Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
- (2020) Christopher T Ritchlin et al. LANCET
- Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas
- (2020) Reuben Moncada et al. NATURE BIOTECHNOLOGY
- Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Philip J Mease et al. LANCET
- Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Atul Deodhar et al. LANCET
- Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial
- (2020) Iain B McInnes et al. LANCET
- Juvenile-Versus Adult-Onset Spondyloarthritis
- (2020) Pamela F. Weiss et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis
- (2020) Bradley Pittam et al. RHEUMATOLOGY
- Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV)
- (2020) Quan Li et al. Scientific Reports
- Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
- (2020) Philip Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- MHC class I associations beyond HLA-B27: the peptide binding hypothesis of psoriatic arthritis and its implications for disease pathogenesis
- (2020) Robert Winchester et al. CURRENT OPINION IN RHEUMATOLOGY
- Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire
- (2020) L. C. Coates et al. Health and Quality of Life Outcomes
- Prevalence and variables associated with fatigue in psoriatic arthritis: a cross-sectional study
- (2020) Joel Shi Quan Tan et al. RHEUMATOLOGY INTERNATIONAL
- Obesity and Psoriatic Arthritis: A Narrative Review
- (2020) Anand Kumthekar et al. Rheumatology and Therapy
- Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey
- (2020) William Tillett et al. Rheumatology and Therapy
- Fibromyalgia in patients with psoriatic arthritis: Impact on disease activity indices, fatigue and health‐related quality of life
- (2020) Noha A. Elsawy et al. International Journal of Rheumatic Diseases
- Applying precision medicine to unmet clinical needs in psoriatic disease
- (2020) Deepak R. Jadon et al. Nature Reviews Rheumatology
- Measuring Outcomes in Psoriatic Arthritis
- (2020) Alexis Ogdie et al. ARTHRITIS CARE & RESEARCH
- Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis
- (2020) Frank Penkava et al. Nature Communications
- Efficacy and Safety of Guselkumab, an Interleukin‐23p19‐Specific Monoclonal Antibody, Through 1 Year in Biologic‐naïve Psoriatic Arthritis Patients
- (2020) Iain B. McInnes et al. Arthritis & Rheumatology
- Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
- (2020) Xenofon Baraliakos et al. ANNALS OF THE RHEUMATIC DISEASES
- Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
- (2020) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of Depression in Patients With Psoriatic Disease: A Systematic Review and Meta-Analysis
- (2020) Aysha Lukmanji et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- The gut microbiota is associated with immune cell dynamics in humans
- (2020) Jonas Schluter et al. NATURE
- Induction of remission in biologic-naive, severe psoriasis and PsA with dual anti-cytokine combination
- (2020) Rebecca H Haberman et al. RHEUMATOLOGY
- Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study
- (2020) Karin Bengtsson et al. RHEUMATOLOGY
- Health-related quality of life in early psoriatic arthritis compared with early rheumatoid arthritis and a general population
- (2020) Mats Geijer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results
- (2019) Philip Mease Arthritis & Rheumatology
- Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial
- (2019) Philip J. Mease et al. Arthritis & Rheumatology
- Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition
- (2019) Jose U. Scher et al. Nature Reviews Rheumatology
- Multidisciplinary Management of Psoriatic Arthritis: The Benefits of a Comprehensive Approach
- (2019) Elisa Visalli et al. ADVANCES IN THERAPY
- The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies
- (2019) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells
- (2019) Eleni P. Mimitou et al. NATURE METHODS
- Anticancer autophagy inhibitors attract ‘resurgent’ interest
- (2019) Elie Dolgin NATURE REVIEWS DRUG DISCOVERY
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis
- (2019) Sarah Ringold et al. Arthritis & Rheumatology
- Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis
- (2019) A. Green et al. BRITISH JOURNAL OF DERMATOLOGY
- Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study
- (2019) Simon Francis Thomsen et al. DERMATOLOGY
- A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
- (2019) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Systematic review of mental health comorbidities in psoriatic arthritis
- (2019) Sizheng Steven Zhao et al. CLINICAL RHEUMATOLOGY
- Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs
- (2019) Neil McHugh et al. JOURNAL OF RHEUMATOLOGY
- Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
- (2019) Joy Feld et al. RHEUMATOLOGY
- Synovial IL‐17A+ CD8+ T cells display a polyfunctional, pro‐inflammatory and tissue‐resident memory phenotype and function in psoriatic arthritis
- (2019) Kathryn J.A. Steel et al. Arthritis & Rheumatology
- Strategies to Improve Outcomes in Psoriatic Arthritis
- (2019) Christopher Ritchlin et al. Current Rheumatology Reports
- The many faces of psoriatic arthritis: their genetic determinism
- (2019) Robert Winchester et al. RHEUMATOLOGY
- Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic Arthritis
- (2018) Alina Soare et al. JOURNAL OF IMMUNOLOGY
- Influence of Disease Manifestations on Health-related Quality of Life in Early Psoriatic Arthritis
- (2018) Kim Wervers et al. JOURNAL OF RHEUMATOLOGY
- Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
- (2018) Farzad Alinaghi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis
- (2018) L.C. Coates et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis
- (2018) Lorenza Scotti et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
- (2018) Kim Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
- (2018) Atul Deodhar et al. Arthritis & Rheumatology
- PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
- (2018) Ana-Maria Orbai et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
- (2018) Philip Mease et al. LANCET
- 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
- (2018) Jasvinder A. Singh et al. Arthritis & Rheumatology
- Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016
- (2017) Ana-Maria Orbai et al. JOURNAL OF RHEUMATOLOGY
- A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis
- (2017) William Tillett et al. JOURNAL OF RHEUMATOLOGY
- Interleukin 23 inhibitors for psoriasis: not just another number
- (2017) Hervé Bachelez LANCET
- Enthesitis: from pathophysiology to treatment
- (2017) Georg Schett et al. Nature Reviews Rheumatology
- Psoriatic Arthritis
- (2017) Christopher T. Ritchlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
- (2017) Philip Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
- (2017) Dafna Gladman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The psychosocial burden of psoriatic arthritis
- (2017) M. Elaine Husni et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)
- (2016) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
- (2016) Ana-Maria Orbai et al. ANNALS OF THE RHEUMATIC DISEASES
- Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
- (2016) Christopher J Edwards et al. ANNALS OF THE RHEUMATIC DISEASES
- Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis
- (2016) Stefán Már Thorarensen et al. ANNALS OF THE RHEUMATIC DISEASES
- Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis
- (2016) Deepak R Jadon et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial
- (2016) M. Cutolo et al. JOURNAL OF RHEUMATOLOGY
- IL-17: overview and role in oral immunity and microbiome
- (2016) L Abusleme et al. ORAL DISEASES
- The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study
- (2016) Lihi Eder et al. Arthritis & Rheumatology
- Brief Report: CXCL10 Is a Possible Biomarker for the Development of Psoriatic Arthritis Among Patients With Psoriasis
- (2016) Fatima Abji et al. Arthritis & Rheumatology
- Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis
- (2015) Axel Patrice Villani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
- (2015) Laura C Coates et al. LANCET
- Biologic Therapy for Psoriatic Arthritis
- (2015) Philip J. Mease RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- The Epidemiology of Psoriatic Arthritis
- (2015) Alexis Ogdie et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis
- (2015) Darren D. O’Rielly et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- It’s not just the joints, it’s the whole thing: qualitative analysis of patients’ experience of flare in psoriatic arthritis
- (2015) Anna R. Moverley et al. RHEUMATOLOGY
- Multidisciplinary dermatology–rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review
- (2015) Tatiana Cobo-Ibáñez et al. RHEUMATOLOGY INTERNATIONAL
- Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype
- (2015) Oliver FitzGerald et al. ARTHRITIS RESEARCH & THERAPY
- Erratum: Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
- (2015) John Bowes et al. Nature Communications
- Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes
- (2014) Yukinori Okada et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative
- (2014) Laure Gossec et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype
- (2014) Muhammad Haroon et al. ANNALS OF THE RHEUMATIC DISEASES
- Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
- (2014) Muhammad Haroon et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
- (2014) Philip J. Mease et al. DRUGS
- Work Productivity Loss and Fatigue in Psoriatic Arthritis
- (2014) J. A. Walsh et al. JOURNAL OF RHEUMATOLOGY
- Development of Criteria to Distinguish Inflammatory from Noninflammatory Arthritis, Enthesitis, Dactylitis, and Spondylitis: A Report from the GRAPPA 2013 Annual Meeting
- (2014) P. J. Mease et al. JOURNAL OF RHEUMATOLOGY
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study
- (2014) W. Tillett et al. RHEUMATOLOGY
- Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
- (2014) Bina Menon et al. Arthritis & Rheumatology
- Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis
- (2013) William Tillett et al. ANNALS OF THE RHEUMATIC DISEASES
- Variants inRUNX3Contribute to Susceptibility to Psoriatic Arthritis, Exhibiting Further Common Ground With Ankylosing Spondylitis
- (2013) Maria Apel et al. ARTHRITIS AND RHEUMATISM
- Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)
- (2013) L.C. Coates et al. BRITISH JOURNAL OF DERMATOLOGY
- Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis
- (2013) S. Fénix-Caballero et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Dactylitis in Psoriatic Arthritis: Prevalence and Response to Therapy in the Biologic Era
- (2013) D. D. Gladman et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study
- (2013) M. Dubreuil et al. RHEUMATOLOGY
- The risks and benefits of glucocorticoid treatment for tendinopathy: A systematic review of the effects of local glucocorticoid on tendon
- (2013) Benjamin John Floyd Dean et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Psoriatic Arthritis: Phenotypic Variance and Nosology
- (2013) Lihi Eder et al. Current Rheumatology Reports
- High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires
- (2012) Muhammad Haroon et al. ANNALS OF THE RHEUMATIC DISEASES
- Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden early arthritis cohort
- (2012) Rosaline van den Berg et al. ANNALS OF THE RHEUMATIC DISEASES
- Sensitivity and specificity of the Classification of Psoriatic Arthritis criteria in early psoriatic arthritis
- (2012) Laura C. Coates et al. ARTHRITIS AND RHEUMATISM
- The Innovative Medicines Initiative: A European Response to the Innovation Challenge
- (2012) M Goldman CLINICAL PHARMACOLOGY & THERAPEUTICS
- Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study
- (2012) Laura Niccoli et al. International Journal of Rheumatic Diseases
- Is methotrexate effective in psoriatic arthritis?
- (2012) Philip J. Mease Nature Reviews Rheumatology
- Prevalence and treatment patterns of psoriatic arthritis in the UK
- (2012) A. Ogdie et al. RHEUMATOLOGY
- A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
- (2012) Gabrielle H. Kingsley et al. RHEUMATOLOGY
- Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis
- (2011) J. Bowes et al. ANNALS OF THE RHEUMATIC DISEASES
- HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype
- (2011) Robert Winchester et al. ARTHRITIS AND RHEUMATISM
- The ClASsification for Psoriatic ARthritis (CASPAR) Criteria - A Retrospective Feasibility, Sensitivity, and Specificity Study
- (2011) W. TILLETT et al. JOURNAL OF RHEUMATOLOGY
- The diagnosis of early psoriatic arthritis in an outpatient dermatological centre for psoriasis
- (2011) C. Bonifati et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesit
- (2011) Philip J. Mease ARTHRITIS CARE & RESEARCH
- Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis
- (2010) V. CHANDRAN et al. JOURNAL OF RHEUMATOLOGY
- Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
- (2010) Ulrike Hüffmeier et al. NATURE GENETICS
- Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis
- (2009) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Axial Psoriatic Arthritis: Update on a Longterm Prospective Study
- (2009) V. CHANDRAN et al. JOURNAL OF RHEUMATOLOGY
- Treatment recommendations for psoriatic arthritis
- (2008) C T Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now